Patient Recruitment/Retention Featured Articles

1. How One Researcher's Personal Study Experience Is Helping Him Better Serve Patients 7/6/2026

   Regeneron Executive Director in Clinical Sciences Kaniel Cassady, Ph.D., reflects on how his industry experience shaped his expectations, questions, and interactions as a patient in a clinical trial and how his patient experience is reshaping his clinical work going forward.

2. The People Behind The Products: Madeline Naylor 6/23/2026

   A clinician's personal story reveals why trial awareness gaps delay patients from finding life-changing care and how data and AI are closing that gap.

3. The Next Chapter Of Obesity And Type 2 Diabetes Care: ADA 2026 Signals A More Personalized Future 6/23/2026

   The American Diabetes Association 2026 conference showed where we are and where we're going with GLP-1 therapies.

4. What ClinOps Gets Wrong About Pediatric Trials 6/12/2026

   Pediatric cancer advocates Brian Burkhardt and Andy Shepperd believe clinical research still confuses retention with relationships. Their lessons on trust, community, and patient support offer valuable insights for clinical operations teams across every therapeutic area.

5. A Blueprint For Addressing Underserved Patient Populations 6/12/2026

   Does our current approach to clinical research truly serve the patients who face the greatest needs? Insmed Inc. CMO Martina Flammer, MD, MBA, explores how to better meet patient needs.

6. New Primary Endpoint For Tetraplegia Drug Gets Support From Patients And The FDA 6/9/2026

   NervGen CEO Adam Rogers discussed why choosing a hand function endpoint for tetraplegia made sense for patients and how regulators helped guide and support the company's decision.

7. Expanding Access To Cell Therapy Trials Beyond AMCs And Into The Community 6/1/2026

   CEO Paul J. Hastings discusses Nkarta's decision to bring outpatient dosing into the community setting, including how it communicated with the FDA on safety and how the changes will improve patient access. 

8. Why Tolerability Will Drive The Next Wave Of Obesity Treatments 5/29/2026

   For the next generation of obesity medicines, enhancing how patients experience therapy will inform discovery and development efforts and may ultimately determine long-term success.

9. Designing Trials Patients Can Actually Complete: Lessons From The SWIFT Deep TMS Study 5/15/2026

   Being time conscious and attuned to patient needs are two contributing factors to trials that recruit and retain patients for the duration.

10. It's A Fact: Sharing Clinical Trial Results With Participants Builds Trust 5/14/2026

    CISCRP experts share results from their annual Perceptions & Insights Study showing that patients continue to place a high value on receiving both individual and overall study results.